In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they intend to reclassify cannabis as being a Program III drug. This rescheduling will figure out that cannabis has legitimate professional medical purposes and will help open up the doorway to exploration on other possible treatment utilizes.Transparency: When selecting a hemp CBD,